I-MAK co-director and co-founder Tahir Amin offers his take on Gilead’s voluntary licensing deals— “Gilead didn’t do this because it wanted to.”
Under pressure, Gilead expands Sovaldi licensing deal to four middle-income countries
I-MAK co-director and co-founder Tahir Amin offers his take on Gilead’s voluntary licensing deals— “Gilead didn’t do this because it wanted to.”
Partner with us now to build
a more just and equitable
medicine system for all.